Anchor Investment Management, LLC - PHARMACYTE BIOTECH INC ownership

PHARMACYTE BIOTECH INC's ticker is PMCB and the CUSIP is 71715X104. A total of 5 filers reported holding PHARMACYTE BIOTECH INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Anchor Investment Management, LLC ownership history of PHARMACYTE BIOTECH INC
ValueSharesWeighting
Q4 2023$58
+1.8%
270.0%0.00%
Q3 2023$57
-26.0%
270.0%0.00%
Q2 2023$77
-2.5%
270.0%0.00%
Q1 2023$790.0%270.0%0.00%
Q4 2022$79
+21.5%
270.0%0.00%
Q3 2022$65
+8.3%
270.0%0.00%
Q2 2022$60
-3.2%
270.0%0.00%
Q1 2022$62
-8.8%
270.0%0.00%
Q4 2021$68
-20.9%
270.0%0.00%
Q3 2021$86
-80.1%
27
-99.9%
0.00%
Q2 2021$432
-36.8%
40,0000.0%0.00%
Q1 2021$684
+155.2%
40,0000.0%0.00%
Q4 2020$268
-60.6%
40,0000.0%0.00%
Q3 2020$680
-33.9%
40,0000.0%0.00%
Q2 2020$1,028
-14.3%
40,0000.0%0.00%
Q1 2020$1,200
-25.9%
40,0000.0%0.00%
Q4 2019$1,620
+10.1%
40,0000.0%0.00%
Q3 2019$1,472
-5.6%
40,0000.0%0.00%
Q2 2019$1,560
-19.8%
40,0000.0%0.00%
Q1 2019$1,944
+31.4%
40,0000.0%0.00%
Q4 2018$1,480
-35.3%
40,0000.0%0.00%
-100.0%
Q3 2018$2,288
-16.3%
40,0000.0%0.00%0.0%
Q2 2018$2,732
+29.4%
40,0000.0%0.00%0.0%
Q1 2018$2,112
-5.4%
40,0000.0%0.00%0.0%
Q4 2017$2,232
-3.8%
40,0000.0%0.00%0.0%
Q3 2017$2,320
+3.3%
40,0000.0%0.00%0.0%
Q2 2017$2,246
-43.0%
40,0000.0%0.00%0.0%
Q1 2017$3,940
-33.8%
40,0000.0%0.00%
-50.0%
Q4 2016$5,95640,0000.00%
Other shareholders
PHARMACYTE BIOTECH INC shareholders Q1 2021
NameSharesValueWeighting ↓
Anchor Investment Management, LLC 40,000$2680.00%
IFP Advisors, Inc 0$00.00%
HUNTINGTON NATIONAL BANK 1$00.00%
Fisher Asset Management, LLC 401,553$3,0000.00%
Peregrine Asset Advisers, Inc. 20,000$00.00%
View complete list of PHARMACYTE BIOTECH INC shareholders